Grundlæggende statistik
| Porteføljeværdi | $ 565.790.302 |
| Nuværende stillinger | 45 |
Seneste beholdninger, ydeevne, AUM (fra 13F, 13D)
Catalio Capital Management, LP har afsløret 45 samlede besiddelser i deres seneste SEC-arkivering. Den seneste porteføljeværdi er beregnet til at være $ 565.790.302 USD. Faktiske aktiver under forvaltning (AUM) er denne værdi plus kontanter (som ikke er oplyst). Catalio Capital Management, LPs største beholdninger er Gilead Sciences, Inc. (US:GILD) , Bristol-Myers Squibb Company (US:BMY) , Boston Scientific Corporation (US:BSX) , BridgeBio Oncology Therapeutics, Inc. (US:BBOT) , and Eli Lilly and Company (US:LLY) . Catalio Capital Management, LPs nye stillinger omfatter BridgeBio Oncology Therapeutics, Inc. (US:BBOT) , Johnson & Johnson (US:JNJ) , Mineralys Therapeutics, Inc. (US:MLYS) , Arcellx, Inc. (US:ACLX) , and Dyne Therapeutics, Inc. (US:DYN) .
Top øger dette kvartal
Vi bruger ændringen i porteføljeallokeringen, fordi dette er den mest meningsfulde metrik. Ændringer kan skyldes handler eller ændringer i aktiekurser.
| Sikkerhed | Aktier (MM) |
Værdi (MM$) |
Portefølje % | ΔPortefølje % |
|---|---|---|---|---|
| GILD / Gilead Sciences, Inc. | 0,29 | 35,51 | 6,2762 | 6,2762 |
| BMY / Bristol-Myers Squibb Company | 0,65 | 34,95 | 6,1768 | 6,1768 |
| BBOT / BridgeBio Oncology Therapeutics, Inc. | 0,41 | 31,41 | 5,5523 | 5,5523 |
| JNJ / Johnson & Johnson | 0,12 | 25,01 | 4,4200 | 4,4200 |
| EW / Edwards Lifesciences Corporation | 0,19 | 15,95 | 2,8183 | 2,8183 |
| MLYS / Mineralys Therapeutics, Inc. | 0,33 | 12,04 | 2,1285 | 2,1285 |
| ACLX / Arcellx, Inc. | 0,16 | 10,18 | 1,7990 | 1,7990 |
| DYN / Dyne Therapeutics, Inc. | 0,52 | 10,17 | 1,7967 | 1,7967 |
| OCUL / Ocular Therapeutix, Inc. | 0,71 | 8,67 | 1,5331 | 1,5331 |
| BSX / Boston Scientific Corporation | 0,36 | 34,37 | 6,0741 | 1,3279 |
Top falder i dette kvartal
Vi bruger ændringen i porteføljeallokeringen, fordi dette er den mest meningsfulde metrik. Ændringer kan skyldes handler eller ændringer i aktiekurser.
| Sikkerhed | Aktier (MM) |
Værdi (MM$) |
Portefølje % | ΔPortefølje % |
|---|---|---|---|---|
| ISRG / Intuitive Surgical, Inc. | 0,03 | 15,41 | 2,7236 | -3,1749 |
| LLY / Eli Lilly and Company | 0,03 | 27,86 | 4,9239 | -3,1692 |
| SLNO / Soleno Therapeutics, Inc. | 0,36 | 16,68 | 2,9488 | -2,2781 |
| NTRA / Natera, Inc. | 0,06 | 14,27 | 2,5215 | -1,8937 |
| QURE / uniQure N.V. | 0,29 | 6,90 | 1,2196 | -1,8336 |
| CYTK / Cytokinetics, Incorporated | 0,26 | 16,42 | 2,9017 | -1,6865 |
| IRON / Disc Medicine, Inc. | 0,11 | 8,77 | 1,5499 | -1,0952 |
| GRAL / GRAIL, Inc. | 0,03 | 2,59 | 0,4586 | -1,0492 |
| RARE / Ultragenyx Pharmaceutical Inc. | 0,16 | 3,74 | 0,6608 | -0,9589 |
| CDTX / Cidara Therapeutics, Inc. | 0,00 | 0,00 | -0,9441 |
13F og Fondsarkivering
Denne formular blev indsendt den 2026-02-17 for rapporteringsperioden 2025-12-31. Klik på linkikonet for at se den fulde transaktionshistorik.
Opgrader for at låse op for premium-data og eksportere til Excel
.
| Sikkerhed | Type | Gennemsnitlig aktiekurs | Aktier (MM) |
Δ Aktier (%) |
Værdi ($MM) |
ΔVærdi (%) |
Portefølje (%) |
ΔPortefølje (%) |
|
|---|---|---|---|---|---|---|---|---|---|
| GILD / Gilead Sciences, Inc. | 0,29 | 35,51 | 6,2762 | 6,2762 | |||||
| BMY / Bristol-Myers Squibb Company | 0,65 | 34,95 | 6,1768 | 6,1768 | |||||
| BSX / Boston Scientific Corporation | 0,36 | 37,06 | 34,37 | 33,86 | 6,0741 | 1,3279 | |||
| BBOT / BridgeBio Oncology Therapeutics, Inc. | 0,41 | 31,41 | 5,5523 | 5,5523 | |||||
| LLY / Eli Lilly and Company | 0,03 | -54,82 | 27,86 | -36,36 | 4,9239 | -3,1692 | |||
| DNTH / Dianthus Therapeutics, Inc. | 0,65 | -2,10 | 26,93 | 2,52 | 4,7604 | -0,0962 | |||
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) | 0,12 | -17,72 | 25,43 | -11,75 | 4,4950 | -0,8326 | |||
| SNDX / Syndax Pharmaceuticals, Inc. | 1,20 | -25,88 | 25,14 | 1,22 | 4,4442 | -0,1483 | |||
| JNJ / Johnson & Johnson | 0,12 | 25,01 | 4,4200 | 4,4200 | |||||
| REGN / Regeneron Pharmaceuticals, Inc. | 0,03 | -15,69 | 23,00 | 15,74 | 4,0650 | 0,3912 | |||
| GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 0,25 | -61,20 | 17,59 | -3,62 | 3,1088 | -0,2652 | |||
| SLNO / Soleno Therapeutics, Inc. | 0,36 | -13,84 | 16,68 | -40,99 | 2,9488 | -2,2781 | |||
| CYTK / Cytokinetics, Incorporated | 0,26 | -42,78 | 16,42 | -33,85 | 2,9017 | -1,6865 | |||
| EW / Edwards Lifesciences Corporation | 0,19 | 15,95 | 2,8183 | 2,8183 | |||||
| ISRG / Intuitive Surgical, Inc. | 0,03 | -61,86 | 15,41 | -51,70 | 2,7236 | -3,1749 | |||
| NTRA / Natera, Inc. | 0,06 | -58,03 | 14,27 | -40,26 | 2,5215 | -1,8937 | |||
| ADPT / Adaptive Biotechnologies Corporation | 0,82 | -7,20 | 13,34 | 0,75 | 2,3571 | -0,0902 | |||
| ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) | 0,10 | -39,24 | 13,29 | -3,49 | 2,3481 | -0,1968 | |||
| SUPN / Supernus Pharmaceuticals, Inc. | 0,26 | -10,32 | 12,80 | -6,73 | 2,2616 | -0,2748 | |||
| GUTS / Fractyl Health, Inc. | 5,49 | 5,32 | 12,08 | 45,74 | 2,1354 | 0,6028 | |||
| MLYS / Mineralys Therapeutics, Inc. | 0,33 | 12,04 | 2,1285 | 2,1285 | |||||
| PHAT / Phathom Pharmaceuticals, Inc. | 0,70 | -38,06 | 11,60 | -12,69 | 2,0496 | -0,4059 | |||
| ADMA / ADMA Biologics, Inc. | 0,56 | -17,54 | 10,30 | 2,60 | 1,8197 | -0,0354 | |||
| ACLX / Arcellx, Inc. | 0,16 | 10,18 | 1,7990 | 1,7990 | |||||
| DYN / Dyne Therapeutics, Inc. | 0,52 | 10,17 | 1,7967 | 1,7967 | |||||
| IRON / Disc Medicine, Inc. | 0,11 | -49,00 | 8,77 | -38,71 | 1,5499 | -1,0952 | |||
| OCUL / Ocular Therapeutix, Inc. | 0,71 | 8,67 | 1,5331 | 1,5331 | |||||
| SEPN / Septerna, Inc. | 0,29 | 0,00 | 8,21 | 48,23 | 1,4505 | 0,4269 | |||
| TARA / Protara Therapeutics, Inc. | 1,45 | -3,63 | 7,71 | 18,08 | 1,3624 | 0,1555 | |||
| QURE / uniQure N.V. | 0,29 | 1,91 | 6,90 | -58,22 | 1,2196 | -1,8336 | |||
| OLMA / Olema Pharmaceuticals, Inc. | 0,27 | 6,68 | 1,1800 | 1,1800 | |||||
| TERN / Terns Pharmaceuticals, Inc. | 0,14 | 5,53 | 0,9779 | 0,9779 | |||||
| RARE / Ultragenyx Pharmaceutical Inc. | 0,16 | -44,19 | 3,74 | -57,33 | 0,6608 | -0,9589 | |||
| HTFL / HeartFlow, Inc. | 0,11 | 3,32 | 0,5866 | 0,5866 | |||||
| GRAL / GRAIL, Inc. | 0,03 | -78,02 | 2,59 | -68,19 | 0,4586 | -1,0492 | |||
| FULC / Fulcrum Therapeutics, Inc. | 0,20 | 2,28 | 0,4024 | 0,4024 | |||||
| BLLN / BillionToOne, Inc. | 0,03 | 2,09 | 0,3689 | 0,3689 | |||||
| ELDN / Eledon Pharmaceuticals, Inc. | 1,26 | 18,72 | 1,90 | -30,79 | 0,3362 | -0,1719 | |||
| HYPR / Hyperfine, Inc. | 1,32 | 92,84 | 1,29 | 30,24 | 0,2285 | 0,0450 | |||
| PVLA / Palvella Therapeutics, Inc. | 0,01 | -12,97 | 1,09 | 45,48 | 0,1934 | 0,0542 | |||
| KPTI / Karyopharm Therapeutics Inc. | 0,14 | 0,00 | 1,05 | 12,51 | 0,1860 | 0,0131 | |||
| MGX / Metagenomi Therapeutics, Inc. | 0,53 | 0,00 | 0,86 | -31,68 | 0,1515 | -0,0803 | |||
| ATAI / AtaiBeckley Inc. | 0,20 | 0,00 | 0,81 | -22,67 | 0,1423 | -0,0502 | |||
| OM / Outset Medical, Inc. | 0,12 | 0,00 | 0,44 | -73,77 | 0,0776 | -0,2312 | |||
| SNSE / Sensei Biotherapeutics, Inc. | 0,01 | 0,00 | 0,16 | 12,95 | 0,0278 | 0,0020 | |||
| RNA / Atrium Therapeutics, Inc. | 0,00 | -100,00 | 0,00 | 0,0000 | |||||
| BBIO / BridgeBio Pharma, Inc. | 0,00 | -100,00 | 0,00 | 0,0000 | |||||
| EXAS / Exact Sciences Corporation | 0,00 | -100,00 | 0,00 | 0,0000 | |||||
| KYTX / Kyverna Therapeutics, Inc. | 0,00 | -100,00 | 0,00 | 0,0000 | |||||
| MLTX / MoonLake Immunotherapeutics | 0,00 | -100,00 | 0,00 | 0,0000 | |||||
| CDTX / Cidara Therapeutics, Inc. | 0,00 | -100,00 | 0,00 | -100,00 | -0,9441 | ||||
| ABBV / AbbVie Inc. | 0,00 | -100,00 | 0,00 | 0,0000 |
